Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
ANI Has Four-Pillar Growth Strategy Following Novitium Deal
As Company Sees Q4 Revenue Increase On The Back Of Generics Sales
Mar 22 2021
•
By
Akriti Seth
ANI Pharma announces a four-pillar growth strategy along with Q4 2020 results • Source: Shutterstock
More from Deals
More from Business